Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

13-week dietary study and in vitro and in vivo genotoxicity studies of a structuring fat produced through a microalgal fermentation process.

Matulka RA, Chan T, Green R, Carney JR, Franklin S, Licari P.

Toxicol Rep. 2015 Dec 29;3:123-134. doi: 10.1016/j.toxrep.2015.12.006. eCollection 2016.

2.

Safety evaluation of oleic-rich triglyceride oil produced by a heterotrophic microalgal fermentation process.

Szabo NJ, Matulka RA, Marone PA, Bauter MR, Chan T, Franklin S, Carney JR, McQuaid SL, Rakitsky W, Green R, Licari P.

Food Chem Toxicol. 2014 Mar;65:301-11. doi: 10.1016/j.fct.2013.12.048. Epub 2014 Jan 3.

PMID:
24394481
3.

Safety evaluation of a high lipid Whole Algalin Flour (WAF) from Chlorella protothecoides.

Szabo NJ, Matulka RA, Kiss L, Licari P.

Regul Toxicol Pharmacol. 2012 Jun;63(1):155-65. doi: 10.1016/j.yrtph.2012.03.011. Epub 2012 Mar 28.

PMID:
22480966
4.

Cytotoxic hypothemycin analogues from Hypomyces subiculosus.

Wee JL, Sundermann K, Licari P, Galazzo J.

J Nat Prod. 2006 Oct;69(10):1456-9.

PMID:
17067161
5.

Preparation of erythromycin analogs having functional groups at C-15.

Ashley GW, Burlingame M, Desai R, Fu H, Leaf T, Licari PJ, Tran C, Abbanat D, Bush K, Macielag M.

J Antibiot (Tokyo). 2006 Jul;59(7):392-401.

PMID:
17025015
6.

Characterization of product capture resin during microbial cultivations.

Frykman S, Tsuruta H, Galazzo J, Licari P.

J Ind Microbiol Biotechnol. 2006 Jun;33(6):445-53. Epub 2006 Feb 11.

PMID:
16474950
7.

Assessment of fed-batch, semicontinuous, and continuous epothilone D production processes.

Frykman SA, Tsuruta H, Licari PJ.

Biotechnol Prog. 2005 Jul-Aug;21(4):1102-8.

PMID:
16080689
8.

Generation of new epothilones by genetic engineering of a polyketide synthase in Myxococcus xanthus.

Tang L, Chung L, Carney JR, Starks CM, Licari P, Katz L.

J Antibiot (Tokyo). 2005 Mar;58(3):178-84.

PMID:
15895525
9.

Production of 8-demethylgeldanamycin and 4,5-epoxy-8-demethylgeldanamycin from a recombinant strain of Streptomyces hygroscopicus.

Buchanan GO, Regentin R, Piagentini M, Rascher A, McDaniel R, Galazzo JL, Licari PJ.

J Nat Prod. 2005 Apr;68(4):607-10.

PMID:
15844961
10.
11.

Isolation and characterization of novel geldanamycin analogues.

Hu Z, Liu Y, Tian ZQ, Ma W, Starks CM, Regentin R, Licari P, Myles DC, Hutchinson CR.

J Antibiot (Tokyo). 2004 Jul;57(7):421-8.

12.
13.

A sensitive and robust method for quantification of intracellular short-chain coenzyme A esters.

Shimazu M, Vetcher L, Galazzo JL, Licari P, Santi DV.

Anal Biochem. 2004 May 1;328(1):51-9.

PMID:
15081907
14.

Isolation and characterization of 7-hydroxy-6-demethyl-6-deoxy-erythromycin D, a new erythromycin analogue, from engineered Saccharopolyspora erythraea.

Starks CM, Rodriguez E, Carney JR, Desai RP, Carreras C, McDaniel R, Hutchinson R, Galazzo JL, Licari PJ.

J Antibiot (Tokyo). 2004 Jan;57(1):64-7. No abstract available.

15.

Precursor-directed biosynthesis of novel triketide lactones.

Regentin R, Kennedy J, Wu N, Carney JR, Licari P, Galazzo J, Desai R.

Biotechnol Prog. 2004 Jan-Feb;20(1):122-7.

PMID:
14763833
16.

Combining classical, genetic, and process strategies for improved precursor-directed production of 6-deoxyerythronolide B analogues.

Desai RP, Leaf T, Hu Z, Hutchinson CR, Hong A, Byng G, Galazzo J, Licari P.

Biotechnol Prog. 2004 Jan-Feb;20(1):38-43.

PMID:
14763821
17.

Isolation and characterization of new epothilone analogues from recombinant Myxococcus xanthus fermentations.

Starks CM, Zhou Y, Liu F, Licari PJ.

J Nat Prod. 2003 Oct;66(10):1313-7.

PMID:
14575429
18.

Nutrient regulation of epothilone biosynthesis in heterologous and native production strains.

Regentin R, Frykman S, Lau J, Tsuruta H, Licari P.

Appl Microbiol Biotechnol. 2003 Jun;61(5-6):451-5. Epub 2003 Mar 6.

PMID:
12764559
19.

Approaches to stabilization of inter-domain recombination in polyketide synthase gene expression plasmids.

Hu Z, Desai RP, Volchegursky Y, Leaf T, Woo E, Licari P, Santi DV, Hutchinson CR, McDaniel R.

J Ind Microbiol Biotechnol. 2003 Mar;30(3):161-7. Epub 2003 Mar 1.

PMID:
12715253
20.

Fluid mechanics, cell distribution, and environment in CellCube bioreactors.

Auniņs JG, Bader B, Caola A, Griffiths J, Katz M, Licari P, Ram K, Ranucci CS, Zhou W.

Biotechnol Prog. 2003 Jan-Feb;19(1):2-8.

PMID:
12572999
21.

Control of secondary metabolite congener distributions via modulation of the dissolved oxygen tension.

Frykman SA, Tsuruta H, Starks CM, Regentin R, Carney JR, Licari PJ.

Biotechnol Prog. 2002 Sep-Oct;18(5):913-20.

PMID:
12363340
22.

Process and metabolic strategies for improved production of Escherichia coli-derived 6-deoxyerythronolide B.

Pfeifer B, Hu Z, Licari P, Khosla C.

Appl Environ Microbiol. 2002 Jul;68(7):3287-92.

23.

Migrastatin and a new compound, isomigrastatin, from Streptomyces platensis.

Woo EJ, Starks CM, Carney JR, Arslanian R, Cadapan L, Zavala S, Licari P.

J Antibiot (Tokyo). 2002 Feb;55(2):141-6.

24.

Enhanced production of heterologous macrolide aglycones by fed-batch cultivation of Streptomyces coelicolor.

Desai RP, Leaf T, Woo E, Licari P.

J Ind Microbiol Biotechnol. 2002 May;28(5):297-301.

PMID:
11986935
25.

Large-scale isolation and crystallization of epothilone D from Myxococcus xanthus cultures.

Arslanian RL, Parker CD, Wang PK, McIntire JR, Lau J, Starks C, Licari PJ.

J Nat Prod. 2002 Apr;65(4):570-2.

PMID:
11975503
26.

Modulation of epothilone analog production through media design.

Frykman S, Tsuruta H, Lau J, Regentin R, Ou S, Reeves C, Carney J, Santi D, Licari P.

J Ind Microbiol Biotechnol. 2002 Jan;28(1):17-20.

PMID:
11938466
27.

Production of a novel FK520 analog in Streptomyces hygroscopicus: improving titer while minimizing impurities.

Regentin R, Cadapan L, Ou S, Zavala S, Licari P.

J Ind Microbiol Biotechnol. 2002 Jan;28(1):12-6.

PMID:
11938465
28.

Optimizing the heterologous production of epothilone D in Myxococcus xanthus.

Lau J, Frykman S, Regentin R, Ou S, Tsuruta H, Licari P.

Biotechnol Bioeng. 2002 May 5;78(3):280-8.

PMID:
11920444
29.

Process development and metabolic engineering for the overproduction of natural and unnatural polyketides.

McDaniel R, Licari P, Khosla C.

Adv Biochem Eng Biotechnol. 2001;73:31-52. Review.

PMID:
11816811
30.

Suspension cultivation of Mycobacterium ulcerans for the production of mycolactones.

Cadapan LD, Arslanian RL, Carney JR, Zavala SM, Small PL, Licari P.

FEMS Microbiol Lett. 2001 Dec 18;205(2):385-9.

31.

Precursor-directed production of erythromycin analogs by Saccharopolyspora erythraea.

Frykman S, Leaf T, Carreras C, Licari P.

Biotechnol Bioeng. 2001 Dec;76(4):303-10.

PMID:
11745157
32.

Saccharopolyspora erythraea-catalyzed bioconversion of 6-deoxyerythronolide B analogs for production of novel erythromycins.

Carreras C, Frykman S, Ou S, Cadapan L, Zavala S, Woo E, Leaf T, Carney J, Burlingame M, Patel S, Ashley G, Licari P.

J Biotechnol. 2002 Jan 18;92(3):217-28.

PMID:
11689246
33.

Enhancing the atom economy of polyketide biosynthetic processes through metabolic engineering.

Lombó F, Pfeifer B, Leaf T, Ou S, Kim YS, Cane DE, Licari P, Khosla C.

Biotechnol Prog. 2001 Jul-Aug;17(4):612-7.

PMID:
11485419
34.

Development and scale-up of a fed-batch process for the production of capsular polysaccharide from Haemophilus influenzae.

Merritt J, Allard G, O'Toole L, Swartz R, Licari P.

J Biotechnol. 2000 Aug 25;81(2-3):189-97.

PMID:
10989178
35.

Precursor-directed biosynthesis of 6-deoxyerythronolide B analogs in Streptomyces coelicolor: understanding precursor effects.

Leaf T, Cadapan L, Carreras C, Regentin R, Ou S, Woo E, Ashley G, Licari P.

Biotechnol Prog. 2000 Jul-Aug;16(4):553-6.

PMID:
10933827
36.

A randomized trial of nortriptyline for smoking cessation.

Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso D.

Arch Intern Med. 1998 Oct 12;158(18):2035-9.

PMID:
9778204
37.

Insect cell hosts for baculovirus expression vectors contain endogenous exoglycosidase activity.

Licari PJ, Jarvis DL, Bailey JE.

Biotechnol Prog. 1993 Mar-Apr;9(2):146-52.

PMID:
7763590
38.

Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group.

Bourdette DN, Prochazka AV, Mitchell W, Licari P, Burks J.

Arch Phys Med Rehabil. 1993 Jan;74(1):26-31.

PMID:
8420515
39.
41.

Production of cell mass and pertussis toxin by Bordetella pertussis.

Licari P, Siber GR, Swartz R.

J Biotechnol. 1991 Sep;20(2):117-29.

PMID:
1367364
43.

The effect of pH on the production of pertussis toxin by Bordetella pertussis.

Licari P, Winberry L, Swartz R.

J Biotechnol. 1991 Feb;17(2):189-93.

PMID:
1366987
44.

A one year study of coronavirus SD infection in mice.

Jankovsky LD, Burks JS, Licari P, Devald BL, Kemp MC.

Adv Exp Med Biol. 1984;173:271-6. No abstract available.

PMID:
6331118
45.

Pathogenesis of coronavirus SD in mice. I. Prominent demyelination in the absence of infectious virus production.

Mendelman PM, Jankovsky LD, Murray RS, Licari P, DeVald B, Gerdes JC, Burks JS.

Arch Neurol. 1983 Aug;40(8):493-8.

PMID:
6870610
46.

The zonules and the elastic microfibrillar system in the ciliary body.

Streeten BW, Licari PA.

Invest Ophthalmol Vis Sci. 1983 Jun;24(6):667-81.

PMID:
6682838
47.

The protein composition of the ocular zonules.

Streeten BW, Swann DA, Licari PA, Robinson MR, Gibson SA, Marsh NJ, Vergnes JP, Freeman IL.

Invest Ophthalmol Vis Sci. 1983 Jan;24(1):119-23.

PMID:
6826307
48.

Immunohistochemical comparison of ocular zonules and the microfibrils of elastic tissue.

Streeten BW, Licari PA, Marucci AA, Dougherty RM.

Invest Ophthalmol Vis Sci. 1981 Jul;21(1 Pt 1):130-5.

PMID:
7019149

Supplemental Content

Loading ...
Support Center